ARCHIVES

FDA Says Medicare Policy On ESAs “Consistent With The Available Data.”

This article is from The Cancer Letter archive.

Vol. 33 No. 38 | October 19, 2007

Download PDF Visit The Full Archive

Related Articles

Gleevec Decreases Recurrence Of Gastrointestinal Tumor

April 27, 2007

In Brief: Appropriations Markup Delayed Until September; FCRC Recompetition Draws 94 Requests for RFP

July 31, 1981

No Benefit For Cetuximab In Early-Stage Colon Cancer

December 25, 2009

NCI awards $42 million for prevention trials consortium.

December 5, 2003

NCI Says. President Bush Visits NIH, Marks Decline In U.S. Cancer Deaths For Second Year.

January 19, 2007

Arizona Cancer Center Seeks NCI Recognition As Comprehensive

May 29, 1987